A Promising H7N9 Vaccine from the Fusion Protein of Hemagglutinin Globular Head and Bacterial FlagellinSeptember 9, 2015
Recombinant subunit vaccines provide protection against viral infections. However, their efficacy is often less potent than vaccines from whole viruses. Studies have shown that bacterial flagellin has strong activity and induces protective immune responses.
Researchers, led by Li Song of the Yangzhou University in China, generated an H7N9 influenza recombinant subunit vaccine with the fusion of the hemagglutinin of the influenza virus (HA1-2) and the potent Salmonella typhimurium flagellin (fliC). The resulting fusion protein, HA1-2-fliC, was then efficiently expressed in an Escherichia coli. In a mouse model vaccination, HA1-2-fliC was found to be capable of triggering the production of neutralizing antibodies, and maintained at high levels for at least 3 months in the vaccinated animals.
The study concludes that immunization with HA1-2-fliC induces potent HA1-2-specific responses, offering significant promise for the development of a successful recombinant subunit vaccine for H7N9.
For more on the study, read the article on BMC Biotechnology.
The Crop Biotech Update is a weekly newsletter of ISAAA, a not-for-profit organization. The CBU is distributed for free to over 23,000 subscribers worldwide to inform them about the key developments in biosciences, especially in agricultural biotechnology. Your support will help us in our mission to feed the world with knowledge. You can help by donating as little as $10.
See more articles:
News from Around the World
- UN Helps Developing Countries Enhance Their Climate Change Adaptation Strategies
- Kenya's NBA Receives Public Comments as it Examines Bt Maize Environmental Release Application
- Kenyan Parliamentarians Endorse Government Plan to Lift GMO Ban
- Major Vernalization Gene in Wheat Identified
- Australian OGTR Approves Field Trials of GM Cotton
- ICAR Emphasizes Importance of Field Trials of GM Crops
- South Korea President Park: Make Agriculture a Key Industry
- EU's Agriculture Committee Opposes National Bans on GM Food and Feed Imports
- Lipid Transfer Protein OsLTPL36 Essential in Seed Development and Seed Quality in Rice
- Modification of Resistance Gene Promoter for Broad-Spectrum Resistance to Bacterial Blight in Rice
- Overexpression of AhNF-YC from Amaranth Modifies Growth and Confers Drought Stress Resistance in Arabidopsis
Beyond Crop Biotech
- Scientists Successfully Edit Dengue Fever Mosquito Genes
- A Promising H7N9 Vaccine from the Fusion Protein of Hemagglutinin Globular Head and Bacterial Flagellin
From the BICs
- Seminar on Global Socio-Economic and Environmental Impacts in Indonesia
- Panel of Scientists to Answer Questions about GMO
- Country Biotech Facts and Trends
Read the latest:
- Crop Biotech Update (May 18, 2022)
- Genome Editing Supplement (May 18, 2022)
- Gene Drive Supplement (April 27, 2022)
Subscribe to CBU: